Perk Pharmaceuticals Limited, a active public limited company, was established on 24 August 1981 in Uttar Pradesh, Uttar Pradesh, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: L24231UP1981PLC005400. Registered under ROC Roc Kanpur. it is listed. It has an authorized capital of ₹8.00 Cr and a paid-up capital of ₹6.38 Cr.
It upholds a active non-compliant status. In 2020, it reported revenue of ₹15.71 Cr and a net worth of ₹6.22 Cr. Employing 9 professional, Its leadership includes Krishna Kaile (Director), Ritu Kaile (Director), Monica Kaile (Director). Past directors included Dhiraj Kumar Kaile, Vikram Kaile, Ramesh Kumar Kaile. It holds ₹3.85 M open charges and ₹6.36 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-7 Industrial Estate Partapur Meerut, Uttar Pradesh, Uttar Pradesh, 250103.
L24231UP1981PLC005400
005400
24 August 1981
₹8.00 Cr
₹6.38 Cr
Roc Kanpur
Listed
Active
Explore comprehensive insights into Perk Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishna Kaile | Director | 01 Oct 1993 | Current |
| Ritu Kaile | Director | 21 Oct 2015 | Current |
| Monica Kaile | Director | 21 Oct 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 22 Oct 2015 | Past |
| Pramod Abcsdd | Director | 22 Oct 2015 | Past |
| Pramod Abcsdd | Managing Director | 06 Sep 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Perk Pharmaceuticals Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 208.04% increase. The company also saw a substantial improvement in profitability, with a 296.18% increase in profit. The company's net worth moved up by a moderate rise of 5.48%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Perk Pharmaceuticals had a promoter holding of 52.30% and a public holding of 47.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,850,000.00
₹63,619,792.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 1987 | Uno Bank Of India | ₹0.18 M | Open |
| 05 Jan 1987 | Union Bank Of India | ₹3.50 M | Open |
| 05 Jan 1987 | Union Bank Of India | ₹0.18 M | Open |
| 10 Jun 1998 | The Pradeshiya Industrial & Investment Corporation Of Ltd. | ₹3.18 Cr | Satisfied |
| 25 May 1998 | The Pracieshiya Industrial & Investment Corporation Of Ltd. | ₹3.18 Cr | Satisfied |
Explore comprehensive loan charge details -
Perk Pharmaceuticals has a workforce of 9 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Perk Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perk Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Perk Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Perk Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.
Progress on Ritu Kaile was appointed as a Director was appointed as a Director on 21 Oct 2015 & has been associated with this company since 10 years 2 months . was documented.
The activity Monica Kaile was appointed as a Director was appointed as a Director on 21 Oct 2015 & has been associated with this company since 10 years 2 months . was completed.
A charge registered on 10 Jun 1998 via Charge ID 90267877 with The Pradeshiya Industrial & Investment Corporation Of Ltd. was fully satisfied on 12 Aug 2009. was recorded as a recent event.
A charge registered on 25 May 1998 via Charge ID 90269168 with The Pracieshiya Industrial & Investment Corporation Of Ltd. was fully satisfied on 12 Aug 2009. was recorded as a recent event.
The CIN of Perk Pharmaceuticals Limited is L24231UP1981PLC005400.
Perk Pharmaceuticals Limited is headquartered at A-7 Industrial Estate Partapur Meerut, Uttar Pradesh, Uttar Pradesh, 250103.
Perk Pharmaceuticals Limited was incorporated on 24 August 1981.
The current directors of Perk Pharmaceuticals Limited are
The primary industry of Perk Pharmaceuticals Limited is Hospital And Medical Care.
Perk Pharmaceuticals Limited is listed.
The authorized capital of Perk Pharmaceuticals Limited is ₹8.00 Cr, and the paid-up capital is ₹6.38 Cr.
The compliance status of Perk Pharmaceuticals Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX